Clinical Trial Update: Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of acarbose on postprandial lipoprotein levels in glucose intolerant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Intolerance

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Glucose Intolerance, Postprandial Hyperglycemia | Phase 4 | Status: COMPLETED